Jean Doh

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursSocial epidemiologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Oct 12, 2024
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

Benjamin J Lee, Jenny Liu, Shawn P Griffin

|Jun 19, 2024
Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvement.

Benjamin J Lee, Zhaohui Arter, Jean Doh

|Nov 07, 2023
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Apr 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change.

Benjamin J Lee, Piyanuch Kongtim, Jean Doh

|Feb 16, 2023
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia.

Benjamin J Lee, Shawn P Griffin, Jean Doh

Pageof 2

Frequent Collaborators

8 joint publications

Benjamin J Lee

7 joint publications

Shawn P Griffin

7 joint publications

Piyanuch Kongtim

6 joint publications

Deepa Jeyakumar